Ankur Bahl
Senior Consultant, Medical Oncology & Hematology Max Super Specialty Hospital (East Block) New Delhi, IndiaPublications
-
Research Article
Quality of life in cancer patients receiving chemotherapy vs immunotherapy in tertiary hospital settings
Author(s): Marwan Mahtook*, Abul Kalam Najmi, Abhishek Raj and Ankur Bahl
There are various therapies in the management of tumours. Immunotherapy is one of the most promising developed treatments included in the second line of many treatment protocols. The quality of life concept was recently evaluated in numerous RCTs to support the evidence in the selection of those therapies in treatment regimens. Aim: To evaluate the quality of life in cancer patients and compare it in two intervention groups, first received chemotherapy alone or plus immunotherapy and second only immunotherapy. Study design and method: Observational cross-sectional study, the study population of 92 cancer patients divided into two groups (Group A; chemo alone or with immunotherapy, and Group B Immunotherapy alone) visited Fortis Memorial Research Institute's chemo-daycare the period between September 11th, 2020 and April 28th, 2021. They evaluated QOL by adminis.. Read More»
Editors List
-
Ahmed Hussien Alshewered
University of Basrah College of Medicine, Iraq
-
Sudhakar Tummala
Department of Electronics and Communication Engineering SRM University – AP, Andhra Pradesh
-
Alphonse Laya
Supervisor of Biochemistry Lab and PhD. students of Faculty of Science, Department of Chemistry and Department of Chemis
-
Fava Maria Giovanna
- Manuprasad Avaronnan
Onkologia i Radioterapia peer review process verified at publons
Indexed In
- Directory of Open Access Journals
- Scimago
- SCOPUS
- EBSCO A-Z
- MIAR
- Euro Pub
- Google Scholar
- Medical Project Poland
- PUBMED
- Cancer Index
- Gdansk University of Technology, Ministry Points 20